Philip Morris International (PM)
NYSE · Stamford, Connecticut, USA · Founded 2008 · CEO Jacek Olczak
Valuation summary
$110.19 fair value versus $186.43 in the market, a difference of -40.9%. Rated Sell.
| Fair value per share | $110.19 |
| Current share price | $186.43 |
| Upside / downside | -40.9% |
| Bear case | $65.10 |
| Bull case | $175.31 |
| Discount rate (WACC) | 8.2% |
| Terminal growth | 2.40% |
| Market capitalisation | $291B |
| EV / Sales | 7.8x |
About Philip Morris International
Spun off from Altria in 2008 to hold the international tobacco business, headquartered in Stamford, Connecticut. Jacek Olczak is CEO. The strategy is an explicit transition away from cigarettes: IQOS heated tobacco, now the leading smoke-free product in dozens of markets, and ZYN nicotine pouches, acquired through Swedish Match in 2022, which have grown extraordinarily fast in the United States. Smoke-free products already generate around 40% of revenue and carry higher margins than combustible cigarettes. It also sells Marlboro outside the US.
Investment case
- ZYN volume growth has been exceptional and the category has better economics than cigarettes.
- IQOS gives a credible path to converting smokers rather than simply managing decline.
- Extremely strong pricing power — tobacco price increases have historically outpaced volume declines every year.
Key risks
- Regulatory risk is permanent and can arrive suddenly, including outright category bans.
- Roughly $45B of net debt from the Swedish Match acquisition needs servicing.
- Many institutional investors are excluded from tobacco by mandate, which caps the buyer base.
Recent developments
- 2026-10-21 · Adjusted operating income tops $5bn for the first time as smoke-free growth accelerates, but a $370m US ZYN investment pushes full-year guidance to the midpoint or lower source
Revenue by segment
| Combustible tobacco | 60% |
| Smoke-free (IQOS, ZYN) | 40% |
Five-year forecast
| Revenue | Free cash flow | |
|---|---|---|
| Year 1 | $46.5B | $10.7B |
| Year 2 | $50.1B | $11.1B |
| Year 3 | $53.9B | $11.6B |
| Year 4 | $58.0B | $12.0B |
| Year 5 | $62.3B | $12.4B |
What the street says
Regarded as the best-positioned tobacco company because of its smoke-free mix, and adjusted operating income passed $5bn for the first time in the third quarter of 2026. Shares fell on the report because a $370m US investment behind ZYN and geopolitical costs pushed full-year guidance to the midpoint or lower. The exclusion of tobacco from many ESG mandates keeps a structural discount in place.
Comparable companies: KO · PG · MC · OR · PEP · ORLY · BUD · YUM
Open the interactive model, price chart and sensitivity grid →